Precision Business Insights
Portfolio

 

Research Reports

In Vitro Toxicology Testing: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

In vitro Toxicology Testing Market: By Product (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Tissue Culture Assays, Western Blots, Cell Based ELISA, Receptor Binding Assays) By Technology (Cellular Imaging Technology, High Throughput Technology, Toxic Genomics, Cell Culture Technology) By Endpoint (Skin Sensitization and Irritation, Cytotoxicity, Neurotoxicity, Geno Toxicity, Ocular Toxicity, Photo Toxicity, Carcinogenicity, Organ Toxicity, Dermal Toxicity) By Method (Ex Vivo Models, Cellular Assays, Biochemical Assays) By End User (Pharmaceutical Industry, Biopharmaceutical Industry, Cosmetics Industry, Household Products Industry, Chemicals Industry, Food Industry) By Geography.

 

Market Outline: In vitro Toxicology Testing Market

 

In vitro toxicology testing is an analysis of effects of the toxic substances on cultured mammalian cells or bacteria. These techniques are primarily employed for identification of potential hazardous chemicals in order to confirm the certain toxic properties at early development stages of therapeutic drugs.

 

Market Dynamics: In vitro Toxicology Testing Market

 

Increase in advanced technologies, rise in R&D activities in cell cultures, rise in demand for in vitro toxicology tests are expected to fuel revenue growth of in vitro toxicology testing market. Furthermore, growing awareness regarding in vitro toxicology tests, growing healthcare concern among individuals, growing economic status of developing regions are expected to offer robust growth opportunities for global in vitro toxicology testing market. On the other hand, stringent regulatory framework, scarcity of in vitro models to detect auto immunity and immune stimulation, technological disadvantages are restraints of the in vitro toxicology testing market.

 

In vitro toxicology testing market is highly fragmented due to presence of many market players, expected to offer lucrative growth during the forecast period. Market players are concentrated on development of new software solutions, introduction of innovative technologies, enhancing in silico simulation methods in toxicological profiling. Companies are adopting various growth strategies such as new product launches, acquisitions and mergers in order to enhance the product portfolio and market presence.

 

Market Scope: In vitro Toxicology Testing Market

 

Global Invitro Toxicology Testing market is segmented based on product, technique, application and end user

 

Based on the product, market is segmented into

  • Bacterial Toxicity Assays
  • Enzyme Toxicity Assays
  • Tissue Culture Assays
  • Western Blots
  • Cell Based ELISA
  • Receptor Binding Assays

 

Based on technology, market is segmented into

  • Cellular Imaging Technology
  • High Throughput Technology
  • Toxic Genomics
  • Cell Culture Technology

 

Based on endpoint, market is segmented into

  • Skin Sensitization and Irritation
  • Cytotoxicity
  • Neurotoxicity
  • Genotoxicity
  • Ocular toxicity
  • Phototoxicity
  • Carcinogenicity
  • Organ toxicity
  • Dermal toxicity

 

Based on Method, market is segmented into

  • Ex Vivo Models
  • Cellular Assays
  • Biochemical Assays

 

Based on end user, market is segmented into

  • Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Cosmetics Industry
  • Chemicals Industry
  • Food Industry

 

Based on Regions, market is segmented into

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

Regional Analysis: In vitro Toxicology Testing Market

 

Global in vitro toxicology testing market is divided into five key regions North America, Europe, Asia Pacific, Latin America, The Middle East and Africa. Europe is expected to dominate in vitro toxicology testing market followed by North America due to surge in cosmetic product testing, favorable support from government. Asia Pacific region is expected to show rapid growth rate owing to burgeoning medical tourism in emerging countries, increase in disposable income, low cost of developments, increase in investments and large pool of population.

 

Competition Assessment:

 

  • Cyprotex (Germany)
  • GE Healthcare (U.S.)
  • Covance (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Eurofins Scientific SE (Luxembourg)
  • Promega Corporation (U.S.)
  • SGS SA (Switzerland)
  • Merck KGaA (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Charles River Laboratories, Inc. (U.S.)

 

Notable Market Developments:

 

  • In September 2017, Aspect Biosystems entered into collaboration with InSCREENeX GmbH and Fraunhofer ITEM (Institute of Toxicology and Experimental Medicine) for application of Lab on a Printer Bio Printing technology to create novel tissues that can be used to improve the reliability of pre-clinical toxicity testing.

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Cyprotex (Germany)
  • GE Healthcare (U.S.)
  • Covance (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Eurofins Scientific SE (Luxembourg)
  • Promega Corporation (U.S.)
  • SGS SA (Switzerland)
  • Merck KGaA (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Charles River Laboratories, Inc. (U.S.)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

Ask An Analyst

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials